Cancer Therapy-Associated Retinopathy

  • Valeska Aparecida Riguette Costa
  • Eduardo Tomazoni
  • Eduardo Büchele Rodrigues
Part of the Retina Atlas book series (RA)


There are two types of cancer therapy-associated retinopathy: associated with radiation or caused by drugs. Treatment in most cases involves suspension or substitution of the drug and depends on the type of the cancer and how advanced it is.


  1. Borrego-Sanz L, et al. Interferon-associated retinopathy in a patient with metastatic melanoma. Arq Bras Oftalmol. 2014;77(5):321–3. Scholar
  2. Gagnon L. New insights on drug retinopathy and enhanced-depth imaging. Retin Physician. 2013;10:34–7.Google Scholar
  3. Gupta A, et al. Radiation retinopathy: case report and review. BMC Ophthalmol. 2007;7:6. Scholar
  4. Langevin S, Chang JS, Chang S. Serous retinopathy associated with cisplatin treatment. Retin Cases Brief Rep. 2017;13(3):211–4. Scholar
  5. Mittra RA, William FM. Drug toxicity of the posterior segment. Ryan’s Retina. 2013;89:1532–50; 58:1083–90.Google Scholar
  6. Omoti AE, Omoti CE. Ocular toxicity of systemic anticancer chemotherapy. Pharm Pract (Granada). 2006;4(2):55–9.CrossRefGoogle Scholar
  7. Srikantia N, et al. Crystalline maculopathy: a rare complication of tamoxifen therapy. J Cancer Res Ther. 2010;6:313–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Valeska Aparecida Riguette Costa
    • 1
  • Eduardo Tomazoni
    • 1
  • Eduardo Büchele Rodrigues
    • 2
    • 3
  1. 1.Ophthalmology, Retina FellowshipVisum RetinaFlorianópolisBrazil
  2. 2.Department of Ophthalmology and Visual SciencesFederal University of São PauloSão PauloBrazil
  3. 3.Department of OphthalmologySaint Louis University School of MedicineSaint LouisUSA

Personalised recommendations